eNauka - pregled
Pregled prema Autor Stanimirovic, Violeta V
Prikaz rezultata 1 do 11 od 11
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2011 | Bioequivalence Studies-25 Year Experience of Novi Sad | Mikov, Momir M   ; Sabo, Ana J; Jakovljevic, Vida S; Djakovic, Kornelija; Tomic, Zdenko S; Golocorbin-Kon, Svetlana ; Stanimirovic, Violeta V | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2013 | "Brilique/Ticagrelor/Safety Profile related to threshold of Toxicological concern/TTC/for impurities Ul127, Ul133, Ul134 and Ul 111 major objections of evaluation documentation for granting MA procedure by Medicines and Medical Devices Agency of Serbia-ALIMS | Stanimirovic, Violeta V; Nikolic, Aleksandra T ; Nikolic, Dejan V; Stanimirovic, Bojan; Stanimirovic, B | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2002 | Contemporary achievements in diagnosis melanoma, in Yugoslavia, using MoleMax-digital microscopy | Nikolic, Dejan V; Nikolic, Aleksandra T ; Stanimirovic, Violeta V; Granic, Miroslav K; Opric, M | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2012 | Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy | Nikolić, Dejan ; Djordjevic, Miroslav L; Granić, Miroslav ; Nikolić, Aleksandra ; Stanimirovic, Violeta V; Zdravković, Darko ; Jelić, Svetlana | Naučni članak | 22M22 - Međunarodni časopis kategorije M22 |
| 2012 | Obesity and its impact on the prediction of coronary heart disease in relation to the metabolic syndrome | Nikolic, Aleksandra T ; Nikolic, Dejan P ; Stanimirovic, Violeta V; Micic, Dragan D | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2011 | Pharmaco-Toxicological Evaluation of Drug Impurities, Benefit/Risk Assessments and Optimising the Safe Use of Medicines-Role of Clinical Pharmacologist | Stanimirovic, Violeta V; Stojiljkovic, M | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2013 | Pitfalls of the Role of FDG-PET in Melanoma Patient with Advanced Disease-Case Report | Nikolic, Dejan V; Granic, Miroslav K; Ivanovic, Nebojsa S ; Zdravkovic, Darko D; Stanimirovic, Violeta V; Nikolic, Aleksandra T | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2013 | "Regulatory dilemma" of ongoing safety review of drug Gilenya (R) (fingolimod)-expierence from Medicines and Medical Devices Agency of Serbia-ALIMS | Stanimirovic, Violeta V; Nikolic, Dejan V; Nikolic, Aleksandra T ; Stanimitovic, B; Stanimirovic, B | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2009 | Regulatory environment in non-eu european countries | Stanimirovic, Violeta V; Stojiljkovic, M | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2013 | Safety assessment reevaluation of Biotechnology-Derived Pharmaceuticals as the imperative for getting renewed Marketing Authorisation Approval (MAA) Experience from Medicies and Medical Devices Agency of Serbia-Alims | Stanimirovic, Violeta V; Nikolic, Dejan V; Nikolic, Aleksandra T ; Stanimitovic, B; Stanimirovic, B | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2013 | Screening of the Pigmented Tumors of the Skin-Single Medical Center Experience | Nikolic, Dejan V; Nikolic, A; Stanimirovic, Violeta V; Filipovic, T; Kostic, J | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |